Does opioid therapy affect quality of care for diabetes mellitus?

American Journal of Managed Care

Volumn 15, Issue 4, 2009, Pages 217-224

  Rose, Adam J ^a,b   Hermos, John A ^b,c   Frayne, Susan M ^d   Pogach, Leonard M ^e   Berlowitz, Dan R ^a,b   Miller, Donald R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e Bldg 70 ^*

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; FENTANYL CITRATE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HYDROCODONE; HYDROMORPHONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHADONE; MORPHINE; MORPHINE SULFATE; OPIATE; OXYCODONE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG USE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; VETERAN;

AGED; ANALGESICS, OPIOID; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; COHORT STUDIES; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES; VETERANS; VISION SCREENING;

EID: 65249150160     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Werner RM, Greenfield S, Fung C,Turner BJ. Measuring quality of care in patients with multiple clinical conditions: summary of a conference conducted by the Society of General Internal Medicine. J Gen Intern Med. 2007;22(8):1206-1211.
2. Desai MM, Rosenheck RA, Druss BG, Perlin JB. Mental disorders and quality of diabetes care in the Veterans Health Administration. Am J Psychiatry. 2002;159(9):1584-1590.
3. Dixon LB, Kreyenbuhl JA, Dickerson FB, et al. A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses [correction appears in Psychiatr Serv. 2004;55(9):1065]. Psychiatr Serv. 2004;55(8):892-900.
4. Frayne SM, Halanych JH, Miller DR, et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med. 2005;165(22): 2631-2638.
5. Meduru P, Helmer D, Rajan M.Tseng CL, Pogach L, Sambamoorthi U. Chronic illness with complexity: implications for performance measurement of optimal glycemic control. J Gen Intern Med. 2007;22(suppl 3):408-418.
6. Redelmeier DA,Tan SH, Booth GL.The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998:338(211:1516-1520.
7. HigashiT, Wenger NS, Adams JL, et al. Relationship between number of medical conditions and quality of care. N Engl J Med. 2007;356(24):2496-2504.
8. LaguTWeiner MG, Hollenbeak CS, et al.The impact of concordant and discordant conditions on the quality of care for hyperlipidemia. J Gen Intern Med. 2008;23(8):1208-1213.
9. Turner BJ, Hollenbeak CS.Weiner M.Ten HaveT, Tang SS. Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med. 2008;148(8):578-586.
10. Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29(3):725-731.
11. Bertakis KD, Azari R, Callahan EJ. Patient pain: its influence on primary care physician-patient interaction. Fam Med. 2003;35(2):119-123.
12. The Use of Opiates for theTreatment of Chronic Pain: A Consensus Statement From the American Academy of Pain Medicine and the American Pain Society. Glenview, IL: American Academy of Pain Medicine and American Pain Society; 1996.
13. IvesTJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:e46.
14. Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the "narc" cabinet. J Gen Intern Med. 2002; 17(51:327-333.
15. ParranT Jr. Prescription drug abuse: a question of balance. Med Clin North Am. 1997;81(4):967-978.
16. Portenoy RK, Dole V, Joseph H, et al. Pain management and chemical dependency: evolving perspectives. JAMA. 1997;278(7):592-593.
17. Reid MC, Engles-Horton LL, Weber MB, Kems RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17(3):173-179.
18. Reuler JB, Girard DE, Nardone DA.The chronic pain syndrome: misconceptions and management. Ann Intern Med. 1980;93(4): 588-596.
19. Savage SR. Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage. 1996;11(5):274-286.
20. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007 [published correction appears in Diabetes Care. 2008;31(6):1271]. Diabetes Care. 2008;31 (3):596-615.
21. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27(suppl 2):B10-B21.
22. Fisher EB, Brownson CA, OToole ML, Anwuri W, Shetty G. Perspectives on self-management from the Diabetes Initiative of the Robert Wood Johnson Foundation. Diabetes Educ. 2007;33(suppl 6):216S-224S.
23. Fisher EB, Brownson CA, OToole ML, et al. The Robert Wood Johnson Foundation Diabetes Initiative: demonstration projects emphasizing self-management. Diabetes Educ. 2007;33(1):83-84, 86-88, 91-92.
24. Dalewitz J, Khan N, Hershey CO. Barriers to control of blood glucose in diabetes mellitus. Am J Med Qual. 2000;15(1):16-25.
25. Drass J, Kell S, Osbom M, et al. Diabetes care for Medicare beneficiaries: attitudes and behaviors of primary care physicians. Diabetes Care. 1998;21(8):1282-1287.
26. Glasgow RE, Hampson SE, Strycker LA, Ruggiero L. Personal- model beliefs and social-environmental barriers related to diabetes self-management. Diabetes Care. 1997;20(4):556-561.
27. Golin CE, DiMatteo MR, Gelberg L.The role of patient participation in the doctor visit: implications for adherence to diabetes care. Diabetes Care. 1996;19(10):1153-1164.
28. Pogach LM, Brietzke SA, Cowan CL Jr, Conlin P, Walder DJ, Sawin CT. Development of evidence-based clinical practice guidelines for diabetes: the Department of Veterans Affairs/Department of Defense guidelines initiative. Diabetes Care. 2004;27(suppl 2):B82-B89.
29. US Department of Veterans Affairs. Clinical practice guidelines: diabetes. Washington, DC; 2009.
30. Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA.The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care. 2001;24(10):1815-1820.
31. Krein SL, Heisler M, Piette JD, Makki F, Kerr EA.The effect of chronic pain on diabetes patients' self-management. Diabetes Care. 2005;28(1):65-70.
32. Mitchinson AR, Kerr EA, Krein SL. Management of chronic noncancer pain by VA primary care providers: when is pain control a priority? Am J Manag Care. 2008;14(2):77-84.
33. Fleming C, Fisher ES, Chang CH, BubolzTA, Malenka DJ. Studying outcomes and hospital utilization in the elderly: the advantages of a merged data base for Medicare and Veterans Affairs hospitals. Med Care. 1992;30(5):377-391.
34. US Department of Justice Web site. Drug Enforcement Administration: drug scheduling, http://www.usdoj.gov/dea/pubs/scheduling. html. Accessed October 7, 2008.
35. Hermos JA, Young MM, Gagnon DR, Fiore LD. Characterizations of long-term oxycodone/acetaminophen prescriptions in veteran patients. Arch Intern Med. 2004;164(21):2361-2366.
36. US Department of Veterans Affairs. Clinical practice guidelines: opioid therapy for chronic pain. Washington, DC; 2009.
37. Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain. 2007;130(1-2): 144-156.
38. Clark JD. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage. 2002;23(2): 131-137.
39. American Psychiatric Association Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-Tft. Washington, DC: American Psychiatric Association; 2000.
40. Hayward RA, HoferTP, Vijan S. Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med. 2006;145(7):520-530.
41. Pogach LM.Tiwari A, Maney M. Rajan M, Miller DR.Aron D. Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control? Am J Manag Care. 2007;13(3):133-140.
42. Action to Control Cardiovascular Risk in Diabetes Study Group. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-2559.